United States Biotechnology & Medical Research

ALX Oncology Holdings Inc (ALXO)

Track

Over the past 90 days, ALX Oncology Holdings Inc. recorded one insider transaction, consisting of a planned sale of 1,404 shares valued at $2,864.16 by SVP of Finance and CAO Shelly Wong. This activity follows the company's May 2026 earnings report, where it reported a 6.25% earnings per share beat.
Ticker: ALXO Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for ALX Oncology Holdings Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.5
Wong Shelly SVP, FINANCE AND CAO Officer
Transaction date
Planned sale
Price
372.37
Quantity 16,266 +35.6%
Value US$4,896,348
2.4
Lettmann Jason CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Sale
Price
81.82
Quantity 29,921 +28.0%
Value US$4,051,437
3.5
Pinto Shelly SVP, FINANCE AND CAO Officer
Transaction date
Sale
Price
78.83
Quantity 52,274 +4.7%
Value US$1,628,586
3.5
Pinto Shelly SVP, FINANCE AND CAO Officer
Transaction date
Sale
Price
2.27
Quantity 565 -0.6%
Value US$1,283
3.1
GOODMAN COREY S Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.57
Quantity 3,184,713 +60.5%
Value US$4,999,999
3.5
Pinto Shelly SVP, FINANCE AND CAO Officer
Transaction date
Planned sale
Price
1.11
Quantity 3,925 -4.3%
Value US$4,357
2.4
Lettmann Jason CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
1.08
Quantity 71,163 +30.4%
Value US$76,892
2.4
Lettmann Jason CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
1.07
Quantity 21,070 +9.9%
Value US$22,461
3.4
Shantharam Harish Chief Financial Officer Officer
Transaction date
Purchase
Price
0.78
Quantity 75,000 +inf%
Value US$58,402
3.5
Pinto Shelly SVP, FINANCE AND CAO Officer
Transaction date
Planned sale
Price
0.64
Quantity 611 -0.7%
Value US$391
2.4
Lettmann Jason CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
0.64
Quantity 2,382 -1.1%
Value US$1,525
3.5
Pinto Shelly SVP, FINANCE AND CAO Officer
Transaction date
Sale
Price
0.45
Quantity 2,011 -2.3%
Value US$905
3.5
Pinto Shelly SVP, FINANCE AND CAO Officer
Transaction date
Sale
Price
0.43
Quantity 1,532 -1.7%
Value US$659
2.4
Lettmann Jason CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
1.15
Quantity 2,159 -1.3%
Value US$2,483
4.2
Pons Jaume PRESIDENT & CSO Officer
Transaction date
Sale
Price
1.15
Quantity 1,326 -0.2%
Value US$1,525
3.5
Pinto Shelly SVP, FINANCE AND CAO Officer
Transaction date
Sale
Price
1.15
Quantity 550 -0.6%
Value US$633
3.5
Pinto Shelly Interim CFO Officer
Transaction date
Sale
Price
1.80
Quantity 2,221 -2.5%
Value US$3,998
3.5
Pinto Shelly Interim CFO Officer
Transaction date
Sale
Price
1.58
Quantity 1,426 -1.6%
Value US$2,253
4.2
Pons Jaume PRESIDENT & CSO Officer
Transaction date
Sale
Price
1.58
Quantity 10,796 -1.8%
Value US$17,060
1.2
Hemrajani Rekha Non-Executive Director
Transaction date
Purchase
Price
1.55
Quantity 30,000 +1000.0%
Value US$46,404
4.4
Randolph Sophia CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
2.58
Quantity 1,365 -0.4%
Value US$3,522
3.5
Pinto Shelly SVP, FINANCE AND CAO Officer
Transaction date
Sale
Price
2.58
Quantity 564 -0.6%
Value US$1,455
4.2
Pons Jaume PRESIDENT & CSO Officer
Transaction date
Sale
Price
2.58
Quantity 1,937 -0.3%
Value US$4,997
4.2
Pons Jaume PRESIDENT & CSO Executive Director
Transaction date
Planned sale
Price
7.90
Quantity 20,000 -3.3%
Value US$158,076
4.2
Pons Jaume Officer Officer
Transaction date
Proposed sale
Price
6.76
Quantity 20,000
Value US$135,200
3.5
Pinto Shelly SVP, FINANCE AND CAO Officer
Transaction date
Sale
Price
5.50
Quantity 1,823 -1.9%
Value US$10,025
4.2
Pons Jaume PRESIDENT & CSO Executive Director
Transaction date
Sale
Price
5.82
Quantity 10,758 -1.8%
Value US$62,599
4.4
Randolph Sophia CHIEF MEDICAL OFFICER Executive Director
Transaction date
Sale
Price
5.82
Quantity 3,273 -1.0%
Value US$19,045
3.5
Pinto Shelly SVP, FINANCE AND CAO Officer
Transaction date
Planned sale
Price
5.82
Quantity 1,373 -1.4%
Value US$7,989
0.6
GARCIA PETER S CHIEF FINANCIAL OFFICER Officer
Transaction date
Purchase
Price
8.53
Quantity 12,000 +10.9%
Value US$102,338
4.2
Pons Jaume PRESIDENT & CSO Executive Director
Transaction date
Planned sale
Price
8.43
Quantity 20,000 -3.2%
Value US$168,652
4.2
Pons Jaume Officer Officer
Transaction date
Proposed sale
Price
8.96
Quantity 20,000
Value US$179,200
4.4
Randolph Sophia CHIEF MEDICAL OFFICER Executive Director
Transaction date
Planned sale
Price
16.67
Quantity 1,797 -0.5%
Value US$29,959
4.4
Randolph Sophia CHIEF MEDICAL OFFICER Executive Director
Transaction date
Planned sale
Price
15.82
Quantity 10,203 -3.0%
Value US$161,380
4.4
Randolph Sophia Officer Officer
Transaction date
Proposed sale
Price
16.21
Quantity 78,000
Value US$1,264,380
4.2
Pons Jaume PRESIDENT & CSO Executive Director
Transaction date
Planned sale
Price
15.92
Quantity 20,000 -3.2%
Value US$318,334
4.2
Pons Jaume Officer Officer
Transaction date
Proposed sale
Price
15.36
Quantity 20,000
Value US$307,200
4.2
Pons Jaume PRESIDENT & CSO Executive Director
Transaction date
Planned sale
Price
14.20
Quantity 50,000 -7.6%
Value US$710,195
4.2
Pons Jaume Officer Officer
Transaction date
Proposed sale
Price
12.89
Quantity 50,000
Value US$644,500
4.2
Pons Jaume PRESIDENT & CSO Executive Director
Transaction date
Planned sale
Price
11.15
Quantity 20,000 -3.1%
Value US$223,036
4.2
Pons Jaume Officer Officer
Transaction date
Proposed sale
Price
10.80
Quantity 20,000
Value US$216,000
2.4
Lettmann Jason CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
11.31
Quantity 4,400 +2.6%
Value US$49,771
3.5
Pinto Shelly SVP, Finance and CAO Officer
Transaction date
Sale
Price
13.60
Quantity 2,717 -3.3%
Value US$36,957
0.6
GARCIA PETER S Chief Financial Officer Officer
Transaction date
Planned sale
Price
15.04
Quantity 1,893 -2.2%
Value US$28,471
4.2
Pons Jaume President & CSO Executive Director
Transaction date
Sale
Price
15.04
Quantity 7,179 -1.1%
Value US$107,972
3.5
Pinto Shelly SVP, Finance and CAO Officer
Transaction date
Planned sale
Price
15.04
Quantity 1,631 -2.0%
Value US$24,530
4.4
Randolph Sophia Chief Medical Officer Executive Director
Transaction date
Sale
Price
15.04
Quantity 3,128 -1.0%
Value US$47,045
3.5
Pinto Shelly VP, Finance and CAO Officer
Transaction date
Sale
Price
6.52
Quantity 7,345 -11.6%
Value US$47,889
4.4
Randolph Sophia Chief Medical Officer Executive Director
Transaction date
Sale
Price
7.34
Quantity 1,605 -0.6%
Value US$11,781
4.2
Pons Jaume President & CEO Executive Director
Transaction date
Sale
Price
7.34
Quantity 3,208 -0.6%
Value US$23,547
3.5
Pinto Shelly VP, Finance and CAO Officer
Transaction date
Planned sale
Price
7.34
Quantity 466 -0.7%
Value US$3,420
0.6
GARCIA PETER S Chief Financial Officer Officer
Transaction date
Planned sale
Price
7.34
Quantity 887 -1.6%
Value US$6,511
3.5
Pinto Shelly VP, Finance and CAO Officer
Transaction date
Planned sale
Price
11.07
Quantity 482 -0.8%
Value US$5,336
4.4
Randolph Sophia Chief Medical Officer Executive Director
Transaction date
Sale
Price
11.07
Quantity 1,617 -0.6%
Value US$17,901
4.2
Pons Jaume President & CEO Executive Director
Transaction date
Sale
Price
11.07
Quantity 3,232 -0.6%
Value US$35,779
0.6
GARCIA PETER S Chief Financial Officer Officer
Transaction date
Planned sale
Price
11.07
Quantity 893 -1.6%
Value US$9,886
3.6
LSV Associates, LLC Large shareholder
Transaction date
Sale
Price
30.23
Quantity 60 -0.0%
Value US$1,814
3.6
LSV Associates, LLC Large shareholder
Transaction date
Sale
Price
30.23
Quantity 440 -0.0%
Value US$13,301
3.6
LSV Associates, LLC Large shareholder
Transaction date
Sale
Price
29.60
Quantity 181 -0.1%
Value US$5,358
3.6
LSV Associates, LLC Large shareholder
Transaction date
Sale
Price
29.60
Quantity 1,329 -0.1%
Value US$39,338
3.6
LSV Associates, LLC Large shareholder
Transaction date
Sale
Price
28.37
Quantity 299 -0.1%
Value US$8,483
3.6
LSV Associates, LLC Large shareholder
Transaction date
Sale
Price
28.37
Quantity 2,196 -0.1%
Value US$62,301
3.6
LSV Associates, LLC Large shareholder
Transaction date
Sale
Price
27.49
Quantity 1,296 -0.5%
Value US$35,627
3.6
LSV Associates, LLC Large shareholder
Transaction date
Sale
Price
27.49
Quantity 9,509 -0.5%
Value US$261,402
3.6
LSV Associates, LLC Large shareholder
Transaction date
Sale
Price
26.48
Quantity 2,339 -0.8%
Value US$61,937
3.6
LSV Associates, LLC Large shareholder
Transaction date
Sale
Price
26.48
Quantity 17,169 -0.8%
Value US$454,635
3.6
LSV Associates, LLC Large shareholder
Transaction date
Sale
Price
25.29
Quantity 1,627 -0.6%
Value US$41,147
3.6
LSV Associates, LLC Large shareholder
Transaction date
Sale
Price
25.29
Quantity 11,945 -0.6%
Value US$302,089
2.4
Lettmann Jason Non-Executive Director Large shareholder
Transaction date
Sale
Price
30.23
Quantity 60 -0.0%
Value US$1,814
2.4
Lettmann Jason Non-Executive Director Large shareholder
Transaction date
Sale
Price
30.23
Quantity 440 -0.0%
Value US$13,301
2.4
Lettmann Jason Non-Executive Director Large shareholder
Transaction date
Sale
Price
29.60
Quantity 181 -0.1%
Value US$5,358
2.4
Lettmann Jason Non-Executive Director Large shareholder
Transaction date
Sale
Price
29.60
Quantity 1,329 -0.1%
Value US$39,338
2.4
Lettmann Jason Non-Executive Director Large shareholder
Transaction date
Sale
Price
28.37
Quantity 299 -0.1%
Value US$8,483
2.4
Lettmann Jason Non-Executive Director Large shareholder
Transaction date
Sale
Price
28.37
Quantity 2,196 -0.1%
Value US$62,301
2.4
Lettmann Jason Non-Executive Director Large shareholder
Transaction date
Sale
Price
27.49
Quantity 1,296 -0.5%
Value US$35,627
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-06 2026-07-01 PlS Planned sale
3.5
Wong Shelly

SVP, FINANCE AND CAO

Officer
16,266 +35.6%
372.37
US$4,896,348 		16,266 +35.6% 372.37 US$4,896,348
2026-03-23 2026-03-19 S Sale
2.4
Lettmann Jason

CHIEF EXECUTIVE OFFICER

Executive Director
29,921 +28.0%
81.82
US$4,051,437 		29,921 +28.0% 81.82 US$4,051,437
2026-03-23 2026-03-19 S Sale
3.5
Pinto Shelly

SVP, FINANCE AND CAO

Officer
52,274 +4.7%
78.83
US$1,628,586 		52,274 +4.7% 78.83 US$1,628,586
2026-02-20 2026-02-18 S Sale
3.5
Pinto Shelly

SVP, FINANCE AND CAO

Officer
565 -0.6%
2.27
US$1,283 		565 -0.6% 2.27 US$1,283
2026-02-04 2026-02-02 B Purchase
3.1
GOODMAN COREY S
Non-Executive Director Large shareholder
3,184,713 +60.5%
1.57
US$4,999,999 		3,184,713 +60.5% 1.57 US$4,999,999
2026-01-07 2026-01-06 PlS Planned sale
3.5
Pinto Shelly

SVP, FINANCE AND CAO

Officer
3,925 -4.3%
1.11
US$4,357 		3,925 -4.3% 1.11 US$4,357
2025-09-18 2025-09-17 B Purchase
2.4
Lettmann Jason

CHIEF EXECUTIVE OFFICER

Executive Director
71,163 +30.4%
1.08
US$76,892 		71,163 +30.4% 1.08 US$76,892
2025-09-18 2025-09-16 B Purchase
2.4
Lettmann Jason

CHIEF EXECUTIVE OFFICER

Executive Director
21,070 +9.9%
1.07
US$22,461 		21,070 +9.9% 1.07 US$22,461
2025-08-20 2025-08-18 B Purchase
3.4
Shantharam Harish

Chief Financial Officer

Officer
75,000 +inf%
0.78
US$58,402 		75,000 +inf% 0.78 US$58,402
2025-08-19 2025-08-15 PlS Planned sale
3.5
Pinto Shelly

SVP, FINANCE AND CAO

Officer
611 -0.7%
0.64
US$391 		611 -0.7% 0.64 US$391
2025-08-19 2025-08-15 PlS Planned sale
2.4
Lettmann Jason

CHIEF EXECUTIVE OFFICER

Executive Director
2,382 -1.1%
0.64
US$1,525 		2,382 -1.1% 0.64 US$1,525
2025-07-08 2025-07-07 S Sale
3.5
Pinto Shelly

SVP, FINANCE AND CAO

Officer
2,011 -2.3%
0.45
US$905 		2,011 -2.3% 0.45 US$905
2025-07-01 2025-06-30 S Sale
3.5
Pinto Shelly

SVP, FINANCE AND CAO

Officer
1,532 -1.7%
0.43
US$659 		1,532 -1.7% 0.43 US$659
2025-02-21 2025-02-19 PlS Planned sale
2.4
Lettmann Jason

CHIEF EXECUTIVE OFFICER

Executive Director
2,159 -1.3%
1.15
US$2,483 		2,159 -1.3% 1.15 US$2,483
2025-02-21 2025-02-19 S Sale
4.2
Pons Jaume

PRESIDENT & CSO

Officer
1,326 -0.2%
1.15
US$1,525 		1,326 -0.2% 1.15 US$1,525
2025-02-21 2025-02-19 S Sale
3.5
Pinto Shelly

SVP, FINANCE AND CAO

Officer
550 -0.6%
1.15
US$633 		550 -0.6% 1.15 US$633
2025-01-08 2025-01-06 S Sale
3.5
Pinto Shelly

Interim CFO

Officer
2,221 -2.5%
1.80
US$3,998 		2,221 -2.5% 1.80 US$3,998
2025-01-02 2024-12-30 S Sale
3.5
Pinto Shelly

Interim CFO

Officer
1,426 -1.6%
1.58
US$2,253 		1,426 -1.6% 1.58 US$2,253
2025-01-02 2024-12-30 S Sale
4.2
Pons Jaume

PRESIDENT & CSO

Officer
10,796 -1.8%
1.58
US$17,060 		10,796 -1.8% 1.58 US$17,060
2024-12-04 2024-12-02 B Purchase
1.2
Hemrajani Rekha
Non-Executive Director
30,000 +1000.0%
1.55
US$46,404 		30,000 +1000.0% 1.55 US$46,404
2024-08-16 2024-08-14 S Sale
4.4
Randolph Sophia

CHIEF MEDICAL OFFICER

Officer
1,365 -0.4%
2.58
US$3,522 		1,365 -0.4% 2.58 US$3,522
2024-08-16 2024-08-14 S Sale
3.5
Pinto Shelly

SVP, FINANCE AND CAO

Officer
564 -0.6%
2.58
US$1,455 		564 -0.6% 2.58 US$1,455
2024-08-16 2024-08-14 S Sale
4.2
Pons Jaume

PRESIDENT & CSO

Officer
1,937 -0.3%
2.58
US$4,997 		1,937 -0.3% 2.58 US$4,997
2024-07-15 2024-07-11 PlS Planned sale
4.2
Pons Jaume

PRESIDENT & CSO

Executive Director
20,000 -3.3%
7.90
US$158,076 		20,000 -3.3% 7.90 US$158,076
2024-07-11 2024-07-11 PrS Proposed sale
4.2
Pons Jaume

Officer

Officer
20,000
6.76
US$135,200 		20,000 6.76 US$135,200
2024-07-09 2024-07-05 S Sale
3.5
Pinto Shelly

SVP, FINANCE AND CAO

Officer
1,823 -1.9%
5.50
US$10,025 		1,823 -1.9% 5.50 US$10,025
2024-07-03 2024-07-01 S Sale
4.2
Pons Jaume

PRESIDENT & CSO

Executive Director
10,758 -1.8%
5.82
US$62,599 		10,758 -1.8% 5.82 US$62,599
2024-07-03 2024-07-01 S Sale
4.4
Randolph Sophia

CHIEF MEDICAL OFFICER

Executive Director
3,273 -1.0%
5.82
US$19,045 		3,273 -1.0% 5.82 US$19,045
2024-07-03 2024-07-01 PlS Planned sale
3.5
Pinto Shelly

SVP, FINANCE AND CAO

Officer
1,373 -1.4%
5.82
US$7,989 		1,373 -1.4% 5.82 US$7,989
2024-06-17 2024-06-13 B Purchase
0.6
GARCIA PETER S

CHIEF FINANCIAL OFFICER

Officer
12,000 +10.9%
8.53
US$102,338 		12,000 +10.9% 8.53 US$102,338
2024-06-06 2024-06-04 PlS Planned sale
4.2
Pons Jaume

PRESIDENT & CSO

Executive Director
20,000 -3.2%
8.43
US$168,652 		20,000 -3.2% 8.43 US$168,652
2024-06-04 2024-06-04 PrS Proposed sale
4.2
Pons Jaume

Officer

Officer
20,000
8.96
US$179,200 		20,000 8.96 US$179,200
2024-05-15 2024-05-13 PlS Planned sale
4.4
Randolph Sophia

CHIEF MEDICAL OFFICER

Executive Director
1,797 -0.5%
16.67
US$29,959 		1,797 -0.5% 16.67 US$29,959
2024-05-15 2024-05-13 PlS Planned sale
4.4
Randolph Sophia

CHIEF MEDICAL OFFICER

Executive Director
10,203 -3.0%
15.82
US$161,380 		10,203 -3.0% 15.82 US$161,380
2024-05-13 2024-05-13 PrS Proposed sale
4.4
Randolph Sophia

Officer

Officer
78,000
16.21
US$1,264,380 		78,000 16.21 US$1,264,380
2024-05-08 2024-05-06 PlS Planned sale
4.2
Pons Jaume

PRESIDENT & CSO

Executive Director
20,000 -3.2%
15.92
US$318,334 		20,000 -3.2% 15.92 US$318,334
2024-05-06 2024-05-06 PrS Proposed sale
4.2
Pons Jaume

Officer

Officer
20,000
15.36
US$307,200 		20,000 15.36 US$307,200
2024-04-18 2024-04-16 PlS Planned sale
4.2
Pons Jaume

PRESIDENT & CSO

Executive Director
50,000 -7.6%
14.20
US$710,195 		50,000 -7.6% 14.20 US$710,195
2024-04-16 2024-04-16 PrS Proposed sale
4.2
Pons Jaume

Officer

Officer
50,000
12.89
US$644,500 		50,000 12.89 US$644,500
2024-04-05 2024-04-04 PlS Planned sale
4.2
Pons Jaume

PRESIDENT & CSO

Executive Director
20,000 -3.1%
11.15
US$223,036 		20,000 -3.1% 11.15 US$223,036
2024-04-04 2024-04-04 PrS Proposed sale
4.2
Pons Jaume

Officer

Officer
20,000
10.80
US$216,000 		20,000 10.80 US$216,000
2024-03-18 2024-03-14 B Purchase
2.4
Lettmann Jason

CHIEF EXECUTIVE OFFICER

Executive Director
4,400 +2.6%
11.31
US$49,771 		4,400 +2.6% 11.31 US$49,771
2024-01-05 2024-01-04 S Sale
3.5
Pinto Shelly

SVP, Finance and CAO

Officer
2,717 -3.3%
13.60
US$36,957 		2,717 -3.3% 13.60 US$36,957
2024-01-03 2023-12-29 PlS Planned sale
0.6
GARCIA PETER S

Chief Financial Officer

Officer
1,893 -2.2%
15.04
US$28,471 		1,893 -2.2% 15.04 US$28,471
2024-01-03 2023-12-29 S Sale
4.2
Pons Jaume

President & CSO

Executive Director
7,179 -1.1%
15.04
US$107,972 		7,179 -1.1% 15.04 US$107,972
2024-01-03 2023-12-29 PlS Planned sale
3.5
Pinto Shelly

SVP, Finance and CAO

Officer
1,631 -2.0%
15.04
US$24,530 		1,631 -2.0% 15.04 US$24,530
2024-01-03 2023-12-29 S Sale
4.4
Randolph Sophia

Chief Medical Officer

Executive Director
3,128 -1.0%
15.04
US$47,045 		3,128 -1.0% 15.04 US$47,045
2023-07-07 2023-07-06 S Sale
3.5
Pinto Shelly

VP, Finance and CAO

Officer
7,345 -11.6%
6.52
US$47,889 		7,345 -11.6% 6.52 US$47,889
2023-07-05 2023-06-30 S Sale
4.4
Randolph Sophia

Chief Medical Officer

Executive Director
1,605 -0.6%
7.34
US$11,781 		1,605 -0.6% 7.34 US$11,781
2023-07-05 2023-06-30 S Sale
4.2
Pons Jaume

President & CEO

Executive Director
3,208 -0.6%
7.34
US$23,547 		3,208 -0.6% 7.34 US$23,547
2023-07-05 2023-06-30 PlS Planned sale
3.5
Pinto Shelly

VP, Finance and CAO

Officer
466 -0.7%
7.34
US$3,420 		466 -0.7% 7.34 US$3,420
2023-07-05 2023-06-30 PlS Planned sale
0.6
GARCIA PETER S

Chief Financial Officer

Officer
887 -1.6%
7.34
US$6,511 		887 -1.6% 7.34 US$6,511
2023-01-03 2022-12-29 PlS Planned sale
3.5
Pinto Shelly

VP, Finance and CAO

Officer
482 -0.8%
11.07
US$5,336 		482 -0.8% 11.07 US$5,336
2023-01-03 2022-12-29 S Sale
4.4
Randolph Sophia

Chief Medical Officer

Executive Director
1,617 -0.6%
11.07
US$17,901 		1,617 -0.6% 11.07 US$17,901
2023-01-03 2022-12-29 S Sale
4.2
Pons Jaume

President & CEO

Executive Director
3,232 -0.6%
11.07
US$35,779 		3,232 -0.6% 11.07 US$35,779
2023-01-03 2022-12-29 PlS Planned sale
0.6
GARCIA PETER S

Chief Financial Officer

Officer
893 -1.6%
11.07
US$9,886 		893 -1.6% 11.07 US$9,886
2021-12-15 2021-12-13 S Sale
3.6
LSV Associates, LLC
Large shareholder
60 -0.0%
30.23
US$1,814 		60 -0.0% 30.23 US$1,814
2021-12-15 2021-12-13 S Sale
3.6
LSV Associates, LLC
Large shareholder
440 -0.0%
30.23
US$13,301 		440 -0.0% 30.23 US$13,301
2021-12-15 2021-12-13 S Sale
3.6
LSV Associates, LLC
Large shareholder
181 -0.1%
29.60
US$5,358 		181 -0.1% 29.60 US$5,358
2021-12-15 2021-12-13 S Sale
3.6
LSV Associates, LLC
Large shareholder
1,329 -0.1%
29.60
US$39,338 		1,329 -0.1% 29.60 US$39,338
2021-12-15 2021-12-13 S Sale
3.6
LSV Associates, LLC
Large shareholder
299 -0.1%
28.37
US$8,483 		299 -0.1% 28.37 US$8,483
2021-12-15 2021-12-13 S Sale
3.6
LSV Associates, LLC
Large shareholder
2,196 -0.1%
28.37
US$62,301 		2,196 -0.1% 28.37 US$62,301
2021-12-15 2021-12-13 S Sale
3.6
LSV Associates, LLC
Large shareholder
1,296 -0.5%
27.49
US$35,627 		1,296 -0.5% 27.49 US$35,627
2021-12-15 2021-12-13 S Sale
3.6
LSV Associates, LLC
Large shareholder
9,509 -0.5%
27.49
US$261,402 		9,509 -0.5% 27.49 US$261,402
2021-12-15 2021-12-13 S Sale
3.6
LSV Associates, LLC
Large shareholder
2,339 -0.8%
26.48
US$61,937 		2,339 -0.8% 26.48 US$61,937
2021-12-15 2021-12-13 S Sale
3.6
LSV Associates, LLC
Large shareholder
17,169 -0.8%
26.48
US$454,635 		17,169 -0.8% 26.48 US$454,635
2021-12-15 2021-12-13 S Sale
3.6
LSV Associates, LLC
Large shareholder
1,627 -0.6%
25.29
US$41,147 		1,627 -0.6% 25.29 US$41,147
2021-12-15 2021-12-13 S Sale
3.6
LSV Associates, LLC
Large shareholder
11,945 -0.6%
25.29
US$302,089 		11,945 -0.6% 25.29 US$302,089
2021-12-15 2021-12-13 S Sale
2.4
Lettmann Jason
Non-Executive Director Large shareholder
60 -0.0%
30.23
US$1,814 		60 -0.0% 30.23 US$1,814
2021-12-15 2021-12-13 S Sale
2.4
Lettmann Jason
Non-Executive Director Large shareholder
440 -0.0%
30.23
US$13,301 		440 -0.0% 30.23 US$13,301
2021-12-15 2021-12-13 S Sale
2.4
Lettmann Jason
Non-Executive Director Large shareholder
181 -0.1%
29.60
US$5,358 		181 -0.1% 29.60 US$5,358
2021-12-15 2021-12-13 S Sale
2.4
Lettmann Jason
Non-Executive Director Large shareholder
1,329 -0.1%
29.60
US$39,338 		1,329 -0.1% 29.60 US$39,338
2021-12-15 2021-12-13 S Sale
2.4
Lettmann Jason
Non-Executive Director Large shareholder
299 -0.1%
28.37
US$8,483 		299 -0.1% 28.37 US$8,483
2021-12-15 2021-12-13 S Sale
2.4
Lettmann Jason
Non-Executive Director Large shareholder
2,196 -0.1%
28.37
US$62,301 		2,196 -0.1% 28.37 US$62,301
2021-12-15 2021-12-13 S Sale
2.4
Lettmann Jason
Non-Executive Director Large shareholder
1,296 -0.5%
27.49
US$35,627 		1,296 -0.5% 27.49 US$35,627
Explore more

More insider trading research around ALX Oncology Holdings Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America